Search Results for 'Immunosuppressants'

Pharmaceutical company Elan has put plans to shed its Athlone division on hold, in spite of indications earlier this year that it was planning to separate the Athlone-based Elan Drug Technologies (EDT) from the rest of the company.

Thalidomide survivors must have access to all relevant State documentation relating to the drug which caused numerous birth defects in the 1960s.

Maggie Woods, who is the chairperson of the Irish Thalidomide Association, says the “thalidomide catastrophe” was not inevitable.

Athlone-based Elan has claimed that a post-hoc analysis showed that its controversial multiple sclerosis drug Tysabri increases the probability of achieving sustained improvement in physical disability over two years when compared to a placebo.

Athlone-based drug developer and its US partner, Biogen Idec, last evening hailed success from a study into the effects of their MS drug, Tysabri in repairing damage to the myelin sheath, a key cause of MS.

Athlone-based pharmaceutical company, Elan, and its US partner Biogen have announced that their drug Tysabri has been proven to significantly reduce the rate of hospitalisation of patients with moderate-to-severe Crohn’s disease.